Close
Biotechgate
| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

News in the Life Sciences Industry

Results 101 - 120 out of 500 displayed.
«  1  2  3  4  5 6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »
Reset 

Kiadis announces new data related to its K-NK cell therapy platform presented today at the ASCO 2020 Virtual Annual Meeting

Read more ››
By: GlobenewsWire - 29 May 2020
Related companies:  Kiadis Pharma N.V.

NextCure Presents Biomarker Data and Updated Clinical Results from Phase 1 Portion of its NC318 Clinical Trial at the 2020 Virtual American Society of Clinical Oncology Annual Meeting

Read more ››
By: GlobenewsWire - 29 May 2020
Related companies:  NextCure, Inc.

Myovant Sciences Announces Additional Positive Efficacy and Cardiovascular Safety Data from Phase 3 HERO Study of Once-Daily, Oral Relugolix in Advanced Prostate Cancer and Publication in the New England Journal of Medicine

Read more ››
By: GlobenewsWire - 29 May 2020
Related companies:  Myovant Sciences, Inc.

Turning Point Therapeutics Presents Preclinical Data For Novel RET Inhibitor Candidate, TPX-0046

Read more ››
By: GlobenewsWire - 29 May 2020
Related companies:  Turning Point Therapeutics, Inc.

TG Therapeutics Announces Final Results of the GENUINE Phase 3 Study Evaluating Ublituximab plus Ibrutinib in Previously Treated High-Risk Chronic Lymphocytic Leukemia at the 56th American Society of Clinical Oncology Annual Meeting

Read more ››
By: GlobenewsWire - 29 May 2020
Related companies:  TG Therapeutics, Inc.

TRACON Pharmaceuticals Highlights Updated Envafolimab Results in MSI-H/dMMR Colorectal Cancer and Results from Clinical Trial of Opdivo and Yervoy Combination Therapy in Undifferentiated Pleomorphic Sarcoma Conducted by Alliance for Clinical Trials i

Read more ››
By: GlobenewsWire - 29 May 2020
Related companies:  TRACON Pharmaceuticals, Inc.

Kiniksa Announces Upcoming Presentation on Mavrilimumab in COVID-19 Pneumonia and Hyperinflammation at the European E-Congress of Rheumatology 2020

Read more ››
By: GlobenewsWire - 29 May 2020
Related companies:  Kiniksa Pharmaceuticals Corp.

Paratek Pharmaceuticals Announces Change to Time of 2020 Annual Meeting of Stockholders

Read more ››
By: GlobenewsWire - 29 May 2020
Related companies:  Paratek Pharmaceuticals, Inc.

Avenue Therapeutics to Host Virtual Annual Meeting of Stockholders

Read more ››
By: GlobenewsWire - 29 May 2020
Related companies:  Avenue Therapeutics, Inc.

Canadian Dermatology Association (CDA) announces the 6 recipients of the 2020 Shade Structure Grant Program

Read more ››
By: GlobenewsWire - 29 May 2020
Related companies:  Canadian Dermatology Association

Aleafia Health Announces Closing of $14.95 Million Bought Deal Offering, Including Full Exercise of the Over-Allotment Option

Read more ››
By: GlobenewsWire - 29 May 2020

Constellation Pharmaceuticals to Participate in Investor Conference

Read more ››
By: GlobenewsWire - 29 May 2020
Related companies:  Constellation Pharmaceuticals, Inc.

SEngine Precision Medicine Presented Data at ASCO 2020 on Clinical Validation of the CLIA Certified PARISĀ® Test, a Revolutionary Organoid Based Assay, to Personalize Cancer Treatments

Read more ››
By: GlobenewsWire - 29 May 2020
Related companies:  SEngine Precision Medicine

Cronos Group Inc. Announces Conference Participation for June 2020

Read more ››
By: GlobenewsWire - 29 May 2020
Related companies:  Cronos Group Inc.

Operational and financial stability are priorities of Olainfarm Group

Read more ››
By: GlobenewsWire - 29 May 2020
Related companies:  Olainfarm

Assure Holdings Reports Fourth Quarter and Full Year 2019 Financial Results

Read more ››
By: GlobenewsWire - 29 May 2020

SI-BONE, Inc. Announces Aetna Establishes Positive Coverage for MIS SI Joint Fusion using the Triangular iFuse Implant System

Read more ››
By: GlobenewsWire - 29 May 2020

Minerva Neurosciences Announces Results From Phase 3 Trial of Roluperidone (MIN-101) for Treatment of Negative Symptoms in Schizophrenia

Read more ››
By: GlobenewsWire - 29 May 2020
Related companies:  Minerva Neurosciences Inc.

Vistin Pharma ASA: Independent Auditor's Report for 2019

Read more ››
By: GlobenewsWire - 29 May 2020

Hamilton Thorne Announces Closing of $7.0 Million Private Placement Financing

Read more ››
By: GlobenewsWire - 29 May 2020
«  1  2  3  4  5 6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »
to the top ↑